Vaccine Optimism Powers Risk Assets to Weekly Gain: EM Review

(Bloomberg) — Emerging-market equities and currencies rose for a third week amid optimism over progress toward a coronavirus vaccine. Moderna Inc. and Pfizer Inc. announced promising clinical trial results even as countries from the U.S. to Japan imposed stricter restrictions to combat the infection. Turkey’s central bank raised interest rates, boosting the lira, while authorities in Indonesia and the Philippines unexpectedly cut borrowing…